Jonathan Freve - 03 Jan 2024 Form 4 Insider Report for Galecto, Inc. (GLTO)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
05 Jan 2024, 16:00:07 UTC
Prior SEC filing
05 Jan 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lori Firmani, attorney-in-fact

Key filing fact

Jonathan Freve filed Form 4 for Galecto, Inc. (GLTO) on 05 Jan 2024.

Key facts

  • This page summarizes Jonathan Freve's Form 4 filing for Galecto, Inc. (GLTO).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 05 Jan 2024, 16:00.

Change

  • Previous filing in this sequence was filed on 05 Jan 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GLTO transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+100,000
Change %
Price
$0.000000
Shares after
100,000
Date
03 Jan 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
100,000
Exercise price
$0.000000
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each restricted stock unit represents the right to receive, at settlement, one share of common stock of Galecto, Inc. One-third of the restricted stock units subject to the award will vest on January 3, 2025 and the remaining restricted stock units will vest ratably every six months thereafter, assuming continued employment through the applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .